Related Experiment Video

Updated: Jun 11, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

Recent Updates on PRDM2 in Colorectal Cancer

Erika Di Zazzo1, Monica Rienzo2, Amelia Casamassimi3

  • 1Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.

Frontiers in Bioscience (Landmark Edition)
|September 30, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
EGFPRDM2/RIZTCGAcolorectal cancertranscriptome

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

Related Experiment Videos

Last Updated: Jun 11, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K

Articles linked to this work by shared authors, journal, and citation graph.

PRDM Proteins Orchestrate Colorectal Cancer Tumorigenesis.

International journal of molecular sciences·2026

PRDM players in central nervous system cancers: State of the art and future perspectives.

Critical reviews in oncology/hematology·2026

[Corrigendum] The p85α regulatory subunit of PI3K mediates cAMP‑PKA and retinoic acid biological effects on MCF7 cell growth and migration.

International journal of oncology·2026

siRNA-based therapeutic candidate targeting PRDM2 for inhibition of lung cancer progression.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Syphilis Transmission: Contagion of Bodies and Words.

The Journal of infectious diseases·2025

A Novel Mutation of TGFB2 Gene Responsible of Loeys-Dietz 4 Syndrome.

International medical case reports journal·2025

Nplate (Romiplostim) Restores Blood Counts and Accelerates Wound Healing Following Radiation Combined Injury in Mice.

Frontiers in bioscience (Landmark edition)·2026

Targeting Integrins in Immunity: Precision Matters for Therapeutic Interventions.

Frontiers in bioscience (Landmark edition)·2026

BTG1 Mediates the Proliferation and Activation of Hepatic Stellate Cells via the JAK2/STAT3 Pathway in Liver Fibrosis.

Frontiers in bioscience (Landmark edition)·2026

Arp2/3 Inhibition Synergizes With PARP Inhibitors by Impairing Homologous Recombination in Gastric Cancer Cells.

Frontiers in bioscience (Landmark edition)·2026

GSDMB as a Therapeutic and Prognostic Target in Clear Cell Renal Cell Carcinoma: Insights From Pyroptosis-Related Gene Analysis.

Frontiers in bioscience (Landmark edition)·2026

Probiotic-Mediated Immune Regulation in Gastric Cancer: Mechanisms, Synergies With Immunotherapy, and Future Directions.

Frontiers in bioscience (Landmark edition)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us